Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Work In Process (2016 - 2018)

Sanofi's Work In Process history spans 4 years, with the latest figure at $4.7 billion for Q4 2018.

  • On a quarterly basis, Work In Process rose 7.34% to $4.7 billion in Q4 2018 year-over-year; TTM through Dec 2018 was $4.7 billion, a 7.34% increase, with the full-year FY2018 number at $4.7 billion, up 7.34% from a year prior.
  • Work In Process hit $4.7 billion in Q4 2018 for Sanofi, up from $4.3 billion in the prior quarter.
  • Over the last five years, Work In Process for SNY hit a ceiling of $4.7 billion in Q4 2018 and a floor of $3.8 billion in Q4 2015.
  • Historically, Work In Process has averaged $4.2 billion across 4 years, with a median of $4.2 billion in 2016.
  • Biggest five-year swings in Work In Process: rose 7.56% in 2016 and later increased 5.89% in 2017.
  • Tracing SNY's Work In Process over 4 years: stood at $3.8 billion in 2015, then rose by 7.56% to $4.1 billion in 2016, then rose by 5.89% to $4.3 billion in 2017, then rose by 7.34% to $4.7 billion in 2018.
  • Business Quant data shows Work In Process for SNY at $4.7 billion in Q4 2018, $4.3 billion in Q4 2017, and $4.1 billion in Q4 2016.